Clinical Trial Update: COMO: Cognition Study With HIV+ Patients (CTNPT 015) [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 cognition study in HIV-positive patients (CTNPT 015) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neurocognitive Disorder

Snippet

Sponsor: Marie-Josée Brouillette | Conditions: HIV - Human Immunodeficiency Virus, Cognitive Symptoms | EARLY_Phase 1 | Status: TERMINATED